These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36163034)

  • 61. A Decision Aid to Promote Appropriate Colorectal Cancer Screening among Older Adults: A Randomized Controlled Trial.
    Lewis CL; Kistler CE; Dalton AF; Morris C; Ferrari R; Barclay C; Brewer NT; Dolor R; Harris R; Vu M; Golin CE
    Med Decis Making; 2018 Jul; 38(5):614-624. PubMed ID: 29847251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Implementing a mHealth intervention to increase colorectal cancer screening among high-risk cancer survivors treated with radiotherapy in the Childhood Cancer Survivor Study (CCSS).
    Henderson TO; Bardwell JK; Moskowitz CS; McDonald A; Vukadinovich C; Lam H; Curry M; Oeffinger KC; Ford JS; Elkin EB; Nathan PC; Armstrong GT; Kim K
    BMC Health Serv Res; 2022 May; 22(1):691. PubMed ID: 35606736
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Randomized, controlled trial of a multimodal intervention to improve cancer screening rates in a safety-net primary care practice.
    Hendren S; Winters P; Humiston S; Idris A; Li SX; Ford P; Specht R; Marcus S; Mendoza M; Fiscella K
    J Gen Intern Med; 2014 Jan; 29(1):41-9. PubMed ID: 23818159
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Can an alert in primary care electronic medical records increase participation in a population-based screening programme for colorectal cancer? COLO-ALERT, a randomised clinical trial.
    Guiriguet-Capdevila C; Muñoz-Ortiz L; Rivero-Franco I; Vela-Vallespín C; Vilarrubí-Estrella M; Torres-Salinas M; Grau-Cano J; Burón-Pust A; Hernández-Rodríguez C; Fuentes-Peláez A; Reina-Rodríguez D; De León-Gallo R; Mendez-Boo L; Torán-Monserrat P
    BMC Cancer; 2014 Mar; 14():232. PubMed ID: 24685117
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial.
    Green BB; Wang CY; Anderson ML; Chubak J; Meenan RT; Vernon SW; Fuller S
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):301-11. PubMed ID: 23460053
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.
    Oyalowo A; Forde KA; Lamanna A; Kochman ML
    JAMA Netw Open; 2022 Mar; 5(3):e224529. PubMed ID: 35357457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial.
    Esplen MJ; Harrington S; Leung YW; Aronson M; Rothenmund H; Semotiuk K; Wong J; Gallinger S; Dicks E; McLaughlin J
    Cancer; 2019 Jul; 125(13):2272-2282. PubMed ID: 30861097
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Comparative Effectiveness Trial of Alternate Formats for Presenting Benefits and Harms Information for Low-Value Screening Services: A Randomized Clinical Trial.
    Sheridan SL; Sutkowi-Hemstreet A; Barclay C; Brewer NT; Dolor RJ; Gizlice Z; Lewis CL; Reuland DS; Golin CE; Kistler CE; Vu M; Harris R
    JAMA Intern Med; 2016 Jan; 176(1):31-41. PubMed ID: 26720730
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
    Selva A; Torà N; Pascual E; Espinàs JA; Baré M
    Colorectal Dis; 2019 Oct; 21(10):1120-1129. PubMed ID: 31099455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled Trial.
    Plys E; Bulliard JL; Chaouch A; Durand MA; van Duuren LA; Brändle K; Auer R; Froehlich F; Lansdorp-Vogelaar I; Corley DA; Selby K
    JMIR Res Protoc; 2023 Sep; 12():e46865. PubMed ID: 37676720
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.
    Walker JG; Bickerstaffe A; Hewabandu N; Maddumarachchi S; Dowty JG; ; Jenkins M; Pirotta M; Walter FM; Emery JD
    BMC Med Inform Decis Mak; 2017 Jan; 17(1):13. PubMed ID: 28103848
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PreView: a Randomized Trial of a Multi-site Intervention in Diverse Primary Care to Increase Rates of Age-Appropriate Cancer Screening.
    Walsh J; Potter M; Salazar R; Ozer E; Gildengorin G; Dass N; Green L
    J Gen Intern Med; 2020 Feb; 35(2):449-456. PubMed ID: 31728894
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.
    Ait Ouakrim D; Lockett T; Boussioutas A; Keogh L; Flander LB; Winship I; Giles GG; Hopper JL; Jenkins MA
    Cancer Causes Control; 2012 Nov; 23(11):1853-64. PubMed ID: 23011536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Increasing uptake of FIT colorectal screening: protocol for the TEMPO randomised controlled trial testing a suggested deadline and a planning tool.
    Robb KA; Kotzur M; Young B; McCowan C; Hollands GJ; Irvine A; Macdonald S; McConnachie A; O'Carroll RE; O'Connor RC; Steele RJC
    BMJ Open; 2023 May; 13(5):e066136. PubMed ID: 37202130
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.